We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » Medical Devices » Research and Development

Research and Development
%{topic} RSS Feed RSS

Luminex logo

Luminex Earns U.S. Funding for COVID-19/Flu/RSV Multi-Test

February 23, 2021
The test is being designed to run on Luminex’s ARIES real-time polymerase chain reaction (RT-PCR) automated molecular diagnostic platforms. Read More
Partner Up, blocks

Becton Dickinson, Scanwell Health Partnering on COVID-19 Rapid Home Test

February 23, 2021
The companies said they are working on enabling the test to automatically report results to public health agencies. Read More
Seegene logo

South Korean Diagnostics Maker Develops New Coronavirus Variant Test

February 22, 2021
The test uses technology that can detect a specific spot where mutation occurs, allowing for precise detection and differentiation of the coronavirus from mutated strains. Read More

U.S. Joins WHO’s ACT Accelerator Program for Pandemic Response

February 15, 2021
The U.S. has joined the World Health Organization (WHO)’s Access to COVID-19 Tools (ACT) Accelerator program, a global effort to speed development and production of coronavirus vaccines, treatments and diagnostic tests, and to help lower-income nations obtain them. Read More

Fibralign Begins European Trial of Surgical Mesh for Preventing Secondary Lymphedema

February 11, 2021
The biodegradable mesh recently earned CE mark certification for use in supporting lymphatic-tissue repair. Read More
COVID-19  Clinical Trial

EmitBio Unveils Positive Early Results for Handheld COVID-19 Therapeutic

January 29, 2021
The handheld device directs precise wavelengths of targeted light to the back of the throat and surrounding tissues and is designed for at-home treatment of mild-to-moderate COVID-19 in adult patients. Read More
Verona Pharma logo

Verona Pharma Ends Enrollment in Inhaler-Administered COVID-19 Drug Pilot

January 19, 2021
The coronavirus treatment candidate, which is delivered by a pressurized metered-dose inhaler, has both bronchodilator and anti-inflammatory activities, the company said. Read More
RedWarningStamp.gif

FDA Warns COVID-19 Tests Could Give False Negatives for New Strains

January 12, 2021
The FDA is currently working with test developers and conducting ongoing data analyses to evaluate all authorized tests, but said it believes there is only a low risk of mutations affecting overall testing accuracy. Read More

FDA Develops Fecal Test for COVID-19

December 15, 2020
There is still no validated stool test, but the FDA’s Office of Vaccines Research and Review has developed a “working assay.” Read More
handshake-430x250.gif

Zeteo Biomedical Partners With Iowa State University on Nasal COVID-19 Vaccine

November 25, 2020
ISU’s vaccine is “intended to address some of the limitations of the vaccines currently in development by targeting room temperature storage and single-dose nasal self-administration as key capabilities,” Zeteo said. Read More

FDA Advisory Committee Shoots Down Neovasc’s Reducer Stent

November 10, 2020
In a separate 13-3 vote with two abstentions, the expert panel concluded that the risks of the Neovasc Reducer System outweigh the benefits for specific patients. Read More
MesaBiotech_Logo.gif

Mesa Biotech Earns Additional BARDA Funding for Rapid COVID-19/Flu Test

November 10, 2020
The test will deliver rapid polymerase chain reaction results in approximately 30 minutes in point-of-care settings. Read More
Previous 1 2 3 4 5 6 7 8 9 … 53 54 Next

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Sanofi-Regeneron_Logos.png

    Sanofi’s and Regeneron’s Libtayo Wins FDA Approval for NSCLC

  • PerkinElmer logo

    PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe

  • WhiteHouse.gif

    President Biden Issues Executive Order on U.S. Supply Chain

  • roche.gif

    Priority Healthcare Settles Diabetes Test Lawsuit with Roche for $43 Million

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing